Stanley C. Jordan

19.2k total citations · 3 hit papers
324 papers, 12.3k citations indexed

About

Stanley C. Jordan is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Stanley C. Jordan has authored 324 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Transplantation, 120 papers in Immunology and 77 papers in Surgery. Recurrent topics in Stanley C. Jordan's work include Renal Transplantation Outcomes and Treatments (142 papers), Renal Diseases and Glomerulopathies (66 papers) and Transplantation: Methods and Outcomes (48 papers). Stanley C. Jordan is often cited by papers focused on Renal Transplantation Outcomes and Treatments (142 papers), Renal Diseases and Glomerulopathies (66 papers) and Transplantation: Methods and Outcomes (48 papers). Stanley C. Jordan collaborates with scholars based in United States, France and Singapore. Stanley C. Jordan's co-authors include Ashley Vo, Mieko Toyoda, Alice Peng, Dolly B. Tyan, Rebecca Sakai, Joseph Kahwaji, Nancy L. Reinsmoen, Rafael Villicana, Jacques M. Lemire and L. Czer and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Stanley C. Jordan

316 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

2008 500 citations Ashley Vo, Mieko Toyoda et al. profile →
Update on the use of immunoglobulin in human disease: A review of evidence

2016 423 citations Stanley C. Jordan, Ashley Vo et al. profile →
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys

2024 48 citations Zhanxiang Wang, David Rincon Fernandez Pacheco et al. Science profile →

Peers

Countries citing papers authored by Stanley C. Jordan

Since Specialization

Citations

This map shows the geographic impact of Stanley C. Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley C. Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley C. Jordan more than expected).

Fields of papers citing papers by Stanley C. Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley C. Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley C. Jordan. The network helps show where Stanley C. Jordan may publish in the future.

Co-authorship network of co-authors of Stanley C. Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley C. Jordan. A scholar is included among the top collaborators of Stanley C. Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley C. Jordan. Stanley C. Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Daratumumab for Treatment of Recurrent FSGS and PGNMID in Kidney Transplant 2025 ·American Journal of Transplantation ·Jun Shoji, Ashley Vo, (unknown), Edmund Huang, Raymond P. Najjar, Sindhu Chandran, Dechu Puliyanda, Robert Vescio, (unknown), Stanley C. Jordan	0
2	Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up 2025 ·American Journal of Transplantation ·Ashley Vo, Edmund Huang, Xiaohai Zhang, Robert Vescio, (unknown), (unknown), (unknown), Noriko Ammerman, (unknown), (unknown), Jun Shoji, Siddharthan Chandran, (unknown), (unknown), Matthew J. Gillespie, David L. Thomas, Borami Shin, Stanley C. Jordan	0
3	A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection 2024 ·Clinical Transplantation ·Fabian Halleck, Georg A. Böhmig, Lionel Couzi, Lionel Rostaing, Gunilla Einecke, (unknown), Christophe Legendre, Robert A. Montgomery, Peter Hughes, Anil Chandraker, Kate Wyburn, Philip F. Halloran, Angela Q. Maldonado, (unknown), Anna Runström, P. Lefèvre, J Tollemar, Stanley C. Jordan	9
4	SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys breakdown → 2024 ·Science ·(unknown), Zhanxiang Wang, David Rincon Fernandez Pacheco, Anna Maria Rinaldi, (unknown), Jasper Callemeyn, Elisabet Van Loon, Baptiste Lamarthée, Ambart E. Covarrubias, Jean Hou, M Yamashita, Haruhiko Akiyama, S. Ananth Karumanchi, Clive N. Svendsen, Paul W. Noble, Stanley C. Jordan, Joshua J. Breunig, Maarten Naesens, Pietro E. Cippà, (unknown)	48
5	Successful treatment of acute antibody-mediated rejection of liver allograft with imlifidase: A case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Steven A. Wisel, Noriko Ammerman, Ashley Vo, Maha Guindi, Kambiz Kosari, (unknown), Tsuyoshi Todo, Nicholas N. Nissen, Stanley C. Jordan, Irene Kim	3
6	Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients 2023 ·Transplant Infectious Disease ·Stanley C. Jordan, Sandy Joung, (unknown), (unknown), (unknown), (unknown), Christine Chang, (unknown), Nancy Sun, J. Patel, M. Kittleson, Edwin C. Frias, John C. Prostko, Joseph E. Ebinger, Susan Cheng, Kimia Sobhani	4
7	HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates 2022 ·Transplantation Direct ·Joshua A. Rushakoff, Loren Gragert, Marcelo J. Pando, Darren Stewart, Edmund Huang, Irene Kim, Stanley C. Jordan, Kelsi Lindblad, Xiaohai Zhang, Peter N. Lalli, J. Patel, Jon Kobashigawa, E. Kransdorf	7
8	Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients 2022 ·Clinical Transplantation ·Meghan Pearl, Patricia L. Weng, (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Zhang, Elaine F. Reed, Irene Kim, Jua Choi, Mark Haas, Xiaohai Zhang, Ashley Vo, Eileen T. Chambers, Robert B. Ettenger, Stanley C. Jordan, Dechu Puliyanda	17
9	Clazakizumab for desensitization in highly sensitized patients awaiting transplantation 2021 ·American Journal of Transplantation ·Ashley Vo, Edmund Huang, Noriko Ammerman, Mieko Toyoda, Shili Ge, Mark Haas, Xiaohai Zhang, Alice Peng, Reiad Najjar, (unknown), (unknown), Supreet Sethi, Kathlyn Lim, Jua Choi, Matthew J. Gillespie, (unknown), Stanley C. Jordan	30
10	Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes 2020 ·Journal of the American Society of Nephrology ·Peter P. Reese, Olivier Aubert, Maarten Naesens, Edmund Huang, Vishnu S. Potluri, Dirk Kuypers, Antoine Bouquegneau, Gillian Divard, Marc Raynaud, Yassine Bouatou, Ashley Vo, Denis Glotz, Christophe Legendre, Carmen Lefaucheur, Stanley C. Jordan, Jean‐Philippe Empana, Xavier Jouven, Alexandre Loupy	49
11	Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients 2014 ·Transplantation ·Ashley Vo, Jua Choi, Kristen Cisneros, Nancy L. Reinsmoen, Mark Haas, Shili Ge, Mieko Toyoda, Joseph Kahwaji, Alice Peng, Rafael Villicana, Stanley C. Jordan	91
12	IFNγ production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens 2011 ·Transplant Immunology ·Mieko Toyoda, Shili Ge, Elina Suviolahti, Pavel N. Pichurin, Borami Shin, (unknown), Ashley Vo, (unknown), (unknown), (unknown), Stanley C. Jordan	21
13	Rituximab: An emerging therapeutic agent for kidney transplantation 2009 ·SHILAP Revista de lepidopterología ·Joseph Kahwaji, (unknown), Stanley C. Jordan, et al.	2
14	Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. 2006 ·PubMed ·Stanley C. Jordan, Ashley Vo, Dolly B. Tyan, (unknown)	27
15	Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience. 2003 ·PubMed ·Stanley C. Jordan, Ashley Vo, Cynthia C. Nast, Dolly B. Tyan	20
16	The Role of Cytokines and Cytokine Gene Polymorphism in T-cell Activation and Allograft Rejection 2000 ·Annals of the Academy of Medicine Singapore ·Suphamai Bunnapradist, Stanley C. Jordan	6
17	Prophylaxis of CMV disease in mismatched patients after heart transplantation using combined antiviral and immunoglobulin therapy 2000 ·The Journal of Heart and Lung Transplantation ·(unknown), L. Czer, Stanley C. Jordan, C Blanche, (unknown), (unknown), René Mathiasen, Meenu Sandhu, Alfredo Trento	1
18	Anti-vascular endothelial cell antibodies in severe preeclampsia 1990 ·American Journal of Obstetrics and Gynecology ·Valerie J. Rappaport, Greigh I. Hirata, Hui‐Kim Yap, Stanley C. Jordan	76
19	Petechiae and urticaria after DTP vaccination: Detection of circulating immune complexes containing vaccine-specific antigens 1986 ·The Journal of Pediatrics ·Karen Lewis, Stanley C. Jordan, James D. Cherry, Rebecca Sakai, Chinh T. Lé	16
20	1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. 1985 ·The Journal of Immunology ·Jacques M. Lemire, John S. Adams, Vali Kermani-Arab, A C Bakke, Rebecca Sakai, Stanley C. Jordan	257

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact